Y. Shemer

Electrophysiological abnormalities in induced pluripotent stem cell‐derived cardiomyocytes generated from Duchenne muscular dystrophy patients

D. Freimark, L. Monserrat, D. Hilfiker-Kleiner, 2019, Journal of cellular and molecular medicine.

CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.

D. Freimark, S. Sperling, O. Binah, 2017, Heart rhythm.

Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9

O. Binah, R. Ben Jehuda, Y. Shemer, 2018, Stem Cell Reviews and Reports.

Investigating the cardiac pathology of SCO2‐mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell–derived cardiomyocytes

H. Mandel, R. Rodenburg, E. Vlodavsky, 2017, Journal of cellular and molecular medicine.

Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9

O. Binah, R. Ben Jehuda, Y. Shemer, 2018, Stem Cell Reviews and Reports.

Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening

M. Davidor, O. Binah, Y. Ben-Haim, 2020, International journal of molecular sciences.

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

E. Arbustini, E. Gottlieb, O. Binah, 2021, International journal of molecular sciences.

Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy

D. Freimark, M. Murgia, O. Binah, 2018, PloS one.

A Method Sustaining the Bioelectric, Biophysical, and Bioenergetic Function of Cultured Rabbit Atrial Cells

O. Binah, Y. Yaniv, Moran Davoodi, 2017, Front. Physiol..